SCHEMBL26912467

SCHEMBL26912467

C(#Cc1c[nH]c2ccccc12)c1ccc(N2CCOCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.53
▸ KDM4E B2RXH2 2/20 0.53
▸ THRB P10828 1/20 0.53
▸ ALDH1A1 P00352 5/20 0.48
▸ PDGFRB P09619 1/20 0.47
▸ JAK1 P23458 1/20 0.46
▸ JAK3 P52333 1/20 0.46
▸ LMNA P02545 2/20 0.42
▸ PDE2A O00408 1/20 0.42
▸ IMPDH2 P12268 1/20 0.42
▸ IMPDH1 P20839 1/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ DRD2 P14416 2/20 0.41
▸ DRD4 P21917 2/20 0.41
▸ DRD3 P35462 2/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ PRKCB P05771 1/20 0.40
▸ PRKCA P17252 1/20 0.40
▸ PRKCH P24723 1/20 0.40
▸ PRKCE Q02156 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30611143 0.78 ELANE (0.46) MAPTKDM4ETHRBALDH1A1PDGFRB
SCHEMBL24331569 0.78 ELANE (0.46) MAPTKDM4ETHRBALDH1A1PDGFRB
SCHEMBL14837630 0.76 IMPDH2 (0.58) MAPTKDM4EALDH1A1LMNAIMPDH2
SCHEMBL26912673 0.76 MAPT (0.59) MAPTKDM4ETHRBALDH1A1PDGFRB
SCHEMBL28561190 0.76 BCHE (0.54) KDM4ELMNAL3MBTL1DRD2DRD4
SCHEMBL1413396 0.72 ALDH1A1 (0.55) MAPTKDM4ETHRBALDH1A1PDGFRB
SCHEMBL26912090 0.72 CYP2D6 (0.65) MAPTKDM4ETHRBALDH1A1CYP2D6
SCHEMBL26911773 0.69 CYP2D6 (0.68) MAPTKDM4ETHRBALDH1A1CYP2D6
SCHEMBL26911783 0.68 HTR1A (0.60) MAPTKDM4ETHRBALDH1A1PDGFRB
SCHEMBL1328701 0.68 TTBK1 (0.51) JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391774-A1 Novel Compounds AC IMMUNE SA (CH) 2023-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391774-A1 Novel Compounds MAPT, PSEN2, PSEN1 MAPT 1/4885KDM4E 4326/4885THRB 3302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback